scholarly journals Nigella sativa oil: A promising prospective antifungal agent in the manufacture of low-salt soft cheese

2021 ◽  
Vol 10 (4) ◽  
Author(s):  
Eman F. Abdel-Latif ◽  
Khaled A. Abbas ◽  
Hani S. Abdelmontaleb ◽  
Shaimaa M. Hamdy
Keyword(s):  
Candida Albicans ◽  
Antifungal Activity ◽  
Physicochemical Properties ◽  
Aspergillus Parasiticus ◽  
Nigella Sativa ◽  
Nigella Sativa Oil ◽  
Soft Cheese ◽  
Low Salt ◽  
Sensorial Evaluation

The current work studied the in-vivo antifungal activity of Nigella sativa oil (NSO) in ultrafiltered low-salt soft cheese as a proposed replacement for the synthetic preservatives which become unacceptable by consumers. Four different concentrations of NSO were examined during the manufacture of the cheese (0.3, 0.5, 1, and 3 % w/w). The effect of NSO supplementation was examined in 3 parallel lines; a ninepoint hedonic scale was used in the sensorial evaluation of soft cheese free of the fungal inoculum, the physicochemical properties of soft cheese were determined during storage as well as anti-fungal effects of different concentrations of NSO on inoculated cheese with different species of fungi: Candida albicans (104 cfu/ml) and Aspergillus parasiticus (102 cfu/ml) before coagulation. The Nigella sativa oil expressed an antifungal activity by using different levels of NSO which significantly reduced and inhibited the growth of the fungal counts (1.4 log cfu/g for Candida albicans and 2.30 log cfu/g for Aspergillus parasiticus) started from 0.5% concentration of NSO on the 14th day of the storage. In addition, it exhibited different physicochemical properties of soft cheese depending on the level of used NSO. However, the Sensory evaluation of cheese samples revealed the acceptance of soft cheese samples with 0.3% and 0.5% of NSO.

The in vivo antifungal activity of the aqueous extract from Nigella sativa seeds

2003 ◽  
Vol 17 (2) ◽  
pp. 183-186 ◽  
Author(s):  
M. A. U. Khan ◽  
M. K. Ashfaq ◽  
H. S. Zuberi ◽  
M. S. Mahmood ◽  
A. H. Gilani
Keyword(s):  
Antifungal Activity ◽  
Aqueous Extract ◽  
Nigella Sativa ◽  
In Vivo Antifungal Activity

Spilanthol as a promising antifungal alkylamide for the treatment of vulvovaginal candidiasis

2021 ◽  
Author(s):  
Rodrigo L Fabri ◽  
Jhamine C O Freitas ◽  
Ari S O Lemos ◽  
Lara M Campos ◽  
Irley O M Diniz ◽  
...  
Keyword(s):  
Cell Wall ◽  
Candida Albicans ◽  
Antifungal Activity ◽  
Cell Membrane ◽  
Multidrug Resistant ◽  
Fungal Strain ◽  
Vulvovaginal Candidiasis ◽  
Biofilm Matrix

Abstract Spilanthol is a bioactive alkylamide from the native Amazon plant species, Acmella oleracea. However, antifungal activities of spilanthol and its application to the therapeutic treatment of candidiasis remains to be explored. This study sought to evaluate the in vitro and in vivo antifungal activity of spilanthol previously isolated from A. oleracea (spilanthol(AcO)) against Candida albicans ATCC® 10231™, a multidrug-resistant fungal strain. Microdilution methods were used to determine inhibitory and fungicidal concentrations of spilanthol(AcO). In planktonic cultures, the fungal growth kinetics, yeast cell metabolic activity, cell membrane permeability and cell wall integrity were investigated. The effect of spilanthol(AcO) on the proliferation and adhesion of fungal biofilms was evaluated by whole slide imaging and scanning electron microscopy. The biochemical composition of the biofilm matrix was also analyzed. In parallel, spilanthol(AcO) was tested in vivo in an experimental vulvovaginal candidiasis model. Our in vitro analyses in C. albicans planktonic cultures detected a significant inhibitory effect of spilanthol(AcO), which affects both yeast cell membrane and cell wall integrity, interfering with the fungus growth. C. albicans biofilm proliferation and adhesion, as well as, carbohydrates and DNA in biofilm matrix were reduced after spilanthol(AcO) treatment. Moreover, infected rats treated with spilanthol(AcO) showed consistent reduction of both fungal burden and inflammatory processes compared to the untreated animals. Altogether, our findings demonstrated that spilanthol(AcO) is an bioactive compound against planktonic and biofilm forms of a multidrug resistant C. albicans strain. Furthermore, spilanthol(AcO) can be potentially considered for therapeutical treatment of vulvovaginal candidiasis caused by C. albicans. Lay Abstract This study sought to evaluate the antifungal activity of spilanthol against Candida albicans ATCC® 10 231™, a multidrug-resistant fungal strain. Our findings demonstrated that spilanthol(AcO) can be potentially considered for therapeutical treatment of vulvovaginal candidiasis caused by C. albicans.

scholarly journals Antifungal activity of Ocimum gratissimum L., Lantana camara L. & Pteleopsis suberosa Engl. & Dies used in the treatment of vulvovaginal candidiasis in Benin

2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Jean Robert Klotoe ◽  
Brice Armand Fanou ◽  
Eric Agbodjento ◽  
Arnaud Houehou ◽  
Lauris Fah ◽  
...  
Keyword(s):  
Candida Albicans ◽  
Antifungal Activity ◽  
Aqueous Extract ◽  
Lantana Camara ◽  
Vulvovaginal Candidiasis ◽  
Reference Drug ◽  
Clinical Strains ◽  
Ocimum Gratissimum

Abstract Background Vulvovaginal candidiasis is a widespread mycotic infection that affects a large proportion of women of childbearing age. Its management in traditional medicine is based on the use of medicinal plants. This study aimed to evaluate the antifungal activity of Ocimum gratissimum L., Lantana camara L. and Pteleopsis suberosa Engl. & Diels used in the treatment of vulvovaginal candidiasis in Benin. Results The data obtained from the in vitro antifungal test show that the strains tested (ATCC 90028 and two clinical strains: 1MA and 3MA) were more sensitive to aqueous extracts with a better effect for Pteleopsis suberosa. This potential of the tested extracts correlated with their richness in total polyphenols. The extract of the Pteleopsis suberosa was very active on the inhibition of the reference strain ATCC 90028. On the clinical strains (1MA and 3MA) the aqueous extract of Pteleopsis suberosa showed a better MIC on the 1MA strain. In vivo model, inoculation of 100 µL of the concentrated Candida albicans suspension 1.5 × 105 UFC/mL induced the candidiasis of the female Wistar rat. The treatment with the aqueous extract of Pteleopsis suberosa, like fluconazole (reference drug), significantly reduced Candida albicans infection at a dose of 100 mg/kg after 1, 7 and 13 days of treatment. Conclusion This study revealed the potential antifungal of the Ocimum gratissimum, Lantana camara and Pteleopsis suberosa. Pteleopsis suberosa has better antifungal activity in vitro and in vivo. These observations justify the use of their medicinal plant in the traditional treatment of vulvovaginal candidiasis in Benin.

In vitro and in vivo activity of chelerythrine against Candida albicans and underlying mechanisms

2019 ◽  
Vol 14 (18) ◽  
pp. 1545-1557 ◽  
Author(s):  
Ying Gong ◽  
Siwen Li ◽  
Weixin Wang ◽  
Yiman Li ◽  
Wenli Ma ◽  
...  
Keyword(s):  
Candida Albicans ◽  
Antifungal Activity ◽  
Calcium Concentration ◽  
Galleria Mellonella ◽  
Hyphal Growth ◽  
Drug Transporter ◽  
Antifungal Effect ◽  
Underlying Mechanisms

Aim: To evaluate whether chelerythrine (CHT) exhibited antifungal activity against Candida albicans in vitro and in vivo and to explore the underlying mechanisms. Materials & methods: Broth microdilution assay and Galleria mellonella model were used to evaluate the antifungal effect in vitro and in vivo, respectively. Mechanism studies were investigated by morphogenesis observation, Fluo-3/AM, DCFH-DA and rhodamine6G assay, respectively. Results: CHT exhibited antifungal activity against C. albicans and preformed biofilms with minimum inhibitory concentrations ranged from 2 to 16 μg/ml. Besides, CHT protected G. mellonella larvae infected by C. albicans. Mechanisms studies revealed that CHT inhibited hyphal growth, increased intracellular calcium concentration, induced accumulation of reactive oxygen species and inhibited drug transporter activity. Conclusion: CHT exhibited antifungal activity against C. albicans.

scholarly journals Ruta graveolens, Pelargonium graveolens E Hibiscus cannabinus COMO INIBIDORES NATURAIS DO CRESCIMENTO DE Candida albicans

2021 ◽  
Vol 58 (1) ◽  
pp. eUJ4124
Author(s):  
Camila Mara dos Reis ◽  
◽  
Letícia Maria Soares Azevedo ◽  
Marisa Cristina da Fonseca Casteluber ◽  
◽  
...  
Keyword(s):  
Candida Albicans ◽  
Antifungal Activity ◽  
Conventional Medicine ◽  
Hibiscus Cannabinus ◽  
In Vivo Studies ◽  
Diffusion Method ◽  
Ruta Graveolens ◽  
Simultaneous Treatment ◽  
Pelargonium Graveolens

Candidiasis is an infection caused by fungi of the genus Candida, Candida albicans being the species that most causes the disease in Brazil. The Fluconazole is the conventional medicine used as a treatment of these infections; however, it causes many adverse reactions in the patient and its continued use can induce the resistance of the pathogen. The medicinal plants can be very effective as an alternative treatment of diseases and have been used in folk medicine for years. In this study, it was evaluated the antifungal activity of extracts of Ruta graveolens, Pelargonium graveolens and Hibiscus cannabinus against the fungal development of Candida albicans, comparing the efficiency of these extracts to Fluconazole. The extracts were prepared in the concentration of 1g of the plant for each 5 mL of alcohol 70%. The data were obtained using the agar diffusion method. The minimum inhibitory concentration test (MIC) was performed, and showed that R. graveolens was able of inhibiting 100% of the pathogen when using 100 mg.ml-1 concentration. From the results obtained, it was possible to conclude that R. graveolens was the most effective extract when compared to Fluconazole, suggesting that this extract can be used as an alternative to conventional treatment to improve the efficiency of current treatments. The extracts of P. graveolens and H. cannabinus also presented antifungal activity but in smaller proportion than Fluconazole. The data from this study suggests that R. graveolens extract can be tested in future in vivo studies with the objective of proposing its use in alternative or simultaneous treatment of the synthetic drug used.

scholarly journals Anti-Candida albicans Activity of Thiazolylhydrazone Derivatives in Invertebrate and Murine Models

2018 ◽  
Vol 4 (4) ◽  
pp. 134 ◽  
Author(s):  
Lana Cruz ◽  
Larissa Lopes ◽  
Felipe de Camargo Ribeiro ◽  
Nívea de Sá ◽  
Cleudiomar Lino ◽  
...  
Keyword(s):  
Candida Albicans ◽  
Antifungal Activity ◽  
Galleria Mellonella ◽  
Larval Survival ◽  
In Vivo Model ◽  
Murine Models ◽  
Greater Wax Moth ◽  
Fungal Load ◽  
Systemic Model

Candidiasis is an opportunistic fungal infection with Candida albicans being the most frequently isolated species. Treatment of these infections is challenging due to resistance that can develop during therapy, and the limited number of available antifungal compounds. Given this situation, the aim of this study was to evaluate the antifungal activity of four thiazolylhydrazone compounds against C. albicans. Thiazolylhydrazone compounds 1, 2, 3, and 4 were found to exert antifungal activity, with MICs of 0.125–16.0 μg/mL against C. albicans. The toxicity of the compounds was evaluated using human erythrocytes and yielded LC50 > 64 μg/mL. The compounds were further evaluated using the greater wax moth Galleria mellonella as an in vivo model. The compounds prolonged larval survival when tested between 5 and 15 mg/kg, performing as well as fluconazole. Compound 2 was evaluated in murine models of oral and systemic candidiasis. In the oral model, compound 2 reduced the fungal load on the mouse tongue; and in the systemic model it reduced the fungal burden found in the kidney when tested at 10 mg/kg. These results show that thiazolylhydrazones are an antifungal towards C. albicans with in vivo efficacy.

scholarly journals The Interactions between the Antimicrobial Peptide P-113 and Living Candida albicans Cells Shed Light on Mechanisms of Antifungal Activity and Resistance

2020 ◽  
Vol 21 (7) ◽  
pp. 2654 ◽  
Author(s):  
Kuang-Ting Cheng ◽  
Chih-Lung Wu ◽  
Bak-Sau Yip ◽  
Ya-Han Chih ◽  
Kuang-Li Peng ◽  
...  
Keyword(s):  
Candida Albicans ◽  
Antifungal Activity ◽  
Antimicrobial Peptide ◽  
Oral Candidiasis ◽  
Immune Deficiency Syndrome ◽  
Deficiency Syndrome ◽  
Salivary Protein ◽  
Histatin 5 ◽  
C Terminus

In the absence of proper immunity, such as in the case of acquired immune deficiency syndrome (AIDS) patients, Candida albicans, the most common human fungal pathogen, may cause mucosal and even life-threatening systemic infections. P-113 (AKRHHGYKRKFH), an antimicrobial peptide (AMP) derived from the human salivary protein histatin 5, shows good safety and efficacy profiles in gingivitis and human immunodeficiency virus (HIV) patients with oral candidiasis. However, little is known about how P-113 interacts with Candida albicans or its degradation by Candida-secreted proteases that contribute to the fungi’s resistance. Here, we use solution nuclear magnetic resonance (NMR) methods to elucidate the molecular mechanism of interactions between P-113 and living Candida albicans cells. Furthermore, we found that proteolytic cleavage of the C-terminus prevents the entry of P-113 into cells and that increasing the hydrophobicity of the peptide can significantly increase its antifungal activity. These results could help in the design of novel antimicrobial peptides that have enhanced stability in vivo and that can have potential therapeutic applications.

scholarly journals Nystatin nanosizing enhances in vitro and in vivo antifungal activity against Candida albicans

2013 ◽  
Vol 68 (9) ◽  
pp. 2099-2105 ◽  
Author(s):  
A. Melkoumov ◽  
M. Goupil ◽  
F. Louhichi ◽  
M. Raymond ◽  
L. de Repentigny ◽  
...  
Keyword(s):  
Candida Albicans ◽  
Antifungal Activity ◽  
In Vivo Antifungal Activity
Sign in / Sign up

Export Citation Format

Share Document